Manoj Raghavan
Overview
Explore the profile of Manoj Raghavan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
69
Citations
1532
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Granadillo E, Fellmeth M, Youssofzadeh V, Heffernan J, Shah-Basak P, Pillay S, et al.
Front Psychol
. 2025 Mar;
16:1492447.
PMID: 40070907
Background: High-definition-tDCS (HD-tDCS) is a recent technology that allows for localized cortical stimulation, but has not yet been investigated as an augmentative therapy while targeting the left temporoparietal cortex in...
2.
Eastley N, Cool P, Jafri M, Raghavan M, Stevenson J
Surg Oncol
. 2025 Feb;
58:102187.
PMID: 39913968
Background: A subgroup of patients present with musculoskeletal (MSK) metastases but no detectable primary tumour. An inability to employ disease-specific treatment means this cohort's median survival is just 6-10 months....
3.
Leung E, Robbins H, Zaman S, Lal N, Morton D, Dew L, et al.
Br J Cancer
. 2024 Oct;
131(11):1805-1813.
PMID: 39478124
Background: The 100,000 Genomes Project established infrastructure for Whole Genome Sequencing (WGS) in the United Kingdom. Methods: A retrospective study of cancer patients recruited to the 100,000 Genomes Project by...
4.
Innes A, Hayden C, Orovboni V, Claudiani S, Fernando F, Khan A, et al.
Leukemia
. 2024 Sep;
38(11):2443-2455.
PMID: 39300220
Asciminib is a potent and selective inhibitor of BCR::ABL1, with potential to avoid toxicity resulting from off-target kinase inhibition. Forty-nine patients treated with asciminib under a managed access program in...
5.
Tummala H, Walne A, Badat M, Patel M, Walne A, Alnajar J, et al.
EMBO Mol Med
. 2024 Aug;
16(10):2560-2582.
PMID: 39198715
Dyskeratosis congenita (DC) is a rare inherited bone marrow failure syndrome, caused by genetic mutations that principally affect telomere biology. Approximately 35% of cases remain uncharacterised at the genetic level....
6.
Raghavan M, Pilet J, Carlson C, Anderson C, Mueller W, Lew S, et al.
Sci Rep
. 2024 Jul;
14(1):17736.
PMID: 39085280
Methods to quantify cortical hyperexcitability are of enormous interest for mapping epileptic networks in patients with focal epilepsy. We hypothesize that, in the resting state, cortical hyperexcitability increases firing-rate correlations...
7.
Coleman D, Keane P, Chin P, Ames L, Kellaway S, Blair H, et al.
iScience
. 2024 Apr;
27(4):109576.
PMID: 38638836
AML is characterized by mutations in genes associated with growth regulation such as internal tandem duplications (ITD) in the receptor kinase FLT3. Inhibitors targeting FLT3 (FLT3i) are being used to...
8.
Kellaway S, Potluri S, Keane P, Blair H, Ames L, Worker A, et al.
Nat Commun
. 2024 Feb;
15(1):1359.
PMID: 38355578
Acute Myeloid Leukemia (AML) is caused by multiple mutations which dysregulate growth and differentiation of myeloid cells. Cells adopt different gene regulatory networks specific to individual mutations, maintaining a rapidly...
9.
Denis C, Dabbs K, Nair V, Mathis J, Almane D, Lakshmanan A, et al.
Ann Clin Transl Neurol
. 2023 Oct;
10(11):2149-2154.
PMID: 37872734
Short-range functional connectivity in the limbic network is increased in patients with temporal lobe epilepsy (TLE), and recent studies have shown that cortical myelin content correlates with fMRI connectivity. We...
10.
Boerger T, Pahapill P, Butts A, Arocho-Quinones E, Raghavan M, Krucoff M
Front Hum Neurosci
. 2023 Jul;
17:1170419.
PMID: 37520929
In recent years, a paradigm shift in neuroscience has been occurring from "localizationism," or the idea that the brain is organized into separately functioning modules, toward "connectomics," or the idea...